# An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder

> **NCT02258828** · PHASE4 · COMPLETED · sponsor: **Sriram Ramaswamy** · enrollment: 26 (actual)

## Conditions studied

- PTSD

## Interventions

- **DRUG:** Memantine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02258828
- **Lead sponsor:** Sriram Ramaswamy
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2020-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02258828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02258828, "An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02258828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*